SAPS II†
|
48 (36–64)
|
50 (38–61)
|
0.535
|
Age†
|
63 (53–75)
|
63 (54–75)
|
0.455
|
Males †
|
30 (62%)
|
30 (62%)
|
1.000
|
Time with mechanical ventilation (h)
|
444 (182–682)
|
84 (0–304)
|
<.001
|
Surgical ICU
|
37 (76%)
|
23 (47%)
|
0.005
|
Medical ICU
|
6 (12%)
|
16 (33%)
|
Interdisciplinary ICU
|
6 (12%)
|
10 (20%)
|
In-house mortality
|
14 (29%)
|
2 (4%)
|
0.002
|
Charlson comorbidity index
|
7 (4–8)
|
5 (3–8)
|
0.350
|
Myokardial infarct
|
3 (6%)
|
0 (0%)
|
0.250
|
Congestive heart failure
|
24 (49%)
|
19 (39%)
|
0.359
|
Peripheral vascular disease
|
11 (22%)
|
5 (10%)
|
0.109
|
Cerebrovascular disease
|
23 (47%)
|
16 (33%)
|
0.265
|
Dementia
|
2 (4%)
|
1 (2%)
|
1.000
|
Chronic lung disease
|
11 (22%)
|
9 (18%)
|
0.791
|
Connective tissue disease
|
1 (2%)
|
0
|
1.000
|
Peptic ulcer
|
0
|
1 (2%)
|
1.000
|
Mild liver disease
|
6 (12%)
|
6 (12%)
|
1.000
|
Diabetes without complications
|
12 (25%)
|
8 (16%)
|
0.388
|
Diabetes with complications
|
2 (4%)
|
2 (4%)
|
1.000
|
Renal disease
|
25 (51%)
|
14 (29%)
|
0.027
|
Tumour
|
5 (10%)
|
13 (27%)
|
0.057
|
Moderate or severe liver disease
|
4 (8%)
|
5 (10%)
|
1.000
|
Malignant tumour
|
2 (4%)
|
6 (12%)
|
0.219
|
AIDS
|
0
|
1 (2%)
|
1.000
|
Hemiplegia
|
16 (33%)
|
8 (16%)
|
0.096
|
Leukemia
|
1 (2%)
|
0
|
1.000
|
Lymphoma
|
0
|
0
|
1.000
|